The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy

American Journal of Obstetrics and Gynecology · 2000 · 3.3K citations

Medicine, Maternal Health, Obstetrics +12

Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia

Richard J. Levine, Chun Sing Lam, Cong Qian et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

Public Health, Maternal Health, Obstetrics +14

Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial

Douglas G. Altman, Guillermo Carroli, Lelia Duley et al. · The Lancet · 2002 · 1.5K citations

Medicine, Maternal Health, Obstetrics +12

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate

Roberto Romero, Jyh Kae Nien, Jimmy Espinoza et al. · The Journal of Maternal-Fetal & Neonatal Medicine · 2008 · 674 citations · Full text

Medicine, Maternal Health, Obstetrics +15

Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy

James M. Roberts, Gail D. Pearson, Jeffrey A. Cutler et al. · Hypertension in Pregnancy · 2003 · 439 citations

Public Health, Maternal Health, Obstetrics +14